These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17047400)

  • 41. Capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer.
    Lee SH; Lee J; Park J; Park SH; Lee KE; Lee SI; Nam E; Park JO; Kim K; Jung CW; Park YS; Yoon SS; Kang WK; Lee MH; Park K; Im YH
    Med Oncol; 2004; 21(3):223-31. PubMed ID: 15456949
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multicentre, phase II study evaluating capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer.
    Fumoleau P; Largillier R; Clippe C; Dièras V; Orfeuvre H; Lesimple T; Culine S; Audhuy B; Serin D; Curé H; Vuillemin E; Morère JF; Montestruc F; Mouri Z; Namer M
    Eur J Cancer; 2004 Mar; 40(4):536-42. PubMed ID: 14962720
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oral capecitabine in anthracycline- and taxane-pretreated advanced/metastatic breast cancer.
    Wist EA; Sommer HH; Ostenstad B; Risberg T; Bremnes Y; Mjaaland I
    Acta Oncol; 2004; 43(2):186-9. PubMed ID: 15163168
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Docetaxel and capecitabine combination chemotherapy for patients with anthracycline-resistant metastatic breast cancer].
    Li SF; Wang X; Wang C; He LH; Shi YH; Hao CF; Dong GL; Tong ZS
    Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):944-6. PubMed ID: 19174000
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and safety of ixabepilone in taxane-resistant patients with metastatic breast cancer previously treated with anthracyclines: results of a phase II study in Japan.
    Aogi K; Rai Y; Ito Y; Masuda N; Watanabe J; Horiguchi J; Tokudome T; Takashima S
    Cancer Chemother Pharmacol; 2013 Jun; 71(6):1427-33. PubMed ID: 23536163
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ixabepilone for the treatment of breast cancer.
    Alvarez RH; Valero V; Hortobagyi GN
    Ann Med; 2011; 43(6):477-86. PubMed ID: 21585248
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gemcitabine/capecitabine in patients with metastatic breast cancer pretreated with anthracyclines and taxanes.
    Andres R; Mayordomo JI; Lara R; Lastra R; Ortega E; Polo E; Lambea J; Isla D; Saenz-Cusi A; Escudero P; Tres A
    Clin Breast Cancer; 2005 Jun; 6(2):158-62. PubMed ID: 16001994
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Experience with capecitabine in patients with anthracycline and/or taxane-resistant recurrent breast cancer].
    Tagaya N; Nakagawa A; Mori S; Tachibana M; Kakihara Y; Hamada K; Suzuki N; Kubota K
    Gan To Kagaku Ryoho; 2005 Aug; 32(8):1135-8. PubMed ID: 16121915
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cost effectiveness of ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment.
    Reed SD; Li Y; Anstrom KJ; Schulman KA
    J Clin Oncol; 2009 May; 27(13):2185-91. PubMed ID: 19332722
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A phase II trial of capecitabine in combination with the farnesyltransferase inhibitor tipifarnib in patients with anthracycline-treated and taxane-resistant metastatic breast cancer: an Eastern Cooperative Oncology Group Study (E1103).
    Li T; Guo M; Gradishar WJ; Sparano JA; Perez EA; Wang M; Sledge GW
    Breast Cancer Res Treat; 2012 Jul; 134(1):345-52. PubMed ID: 22547107
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy and safety of capecitabine in combination with docetaxel and mitomycin C in patients with pre-treated pancreatic, gallbladder, and bile duct carcinoma.
    Kruth J; Nissen J; Ernst T; Kripp M; Lukan N; Merx K; Hofmann WK; Hochhaus A; Hofheinz RD
    J Cancer Res Clin Oncol; 2010 Dec; 136(12):1845-51. PubMed ID: 20224968
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mitomycin C and Capecitabine (MiX Trial) for Therapy of Patients with Metastasized, Breast Cancer Pretreated with Anthracycline.
    Almstedt K; Fasching PA; Scharl A; Rauh C; Rack B; Hein A; Hack CC; Bayer CM; Jud SM; Schrauder MG; Beckmann MW; Lux MP
    Anticancer Res; 2016 Jan; 36(1):419-25. PubMed ID: 26722076
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Combination of docetaxel and capecitabine for the treatment of anthracycline-resistant advanced breast carcinoma].
    Zhang JD; Shao ZY
    Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):787-9. PubMed ID: 19173816
    [TBL] [Abstract][Full Text] [Related]  

  • 54. What is the best chemotherapy treatment option for anthracycline and taxane pretreated metastatic breast cancer?
    Verma S; Trudeau M; Dranitsaris G; Clemons M; Joy AA; MacKey JR
    J Clin Oncol; 2005 Sep; 23(25):6260; author reply 6261. PubMed ID: 16135495
    [No Abstract]   [Full Text] [Related]  

  • 55. Prolonged disease control in a patient with anthracycline- and taxane-resistant breast cancer.
    Castaneda CA; Gómez HL
    Clin Breast Cancer; 2009 Nov; 9(4):E1-3. PubMed ID: 19933071
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ixabepilone plus capecitabine with capecitabine alone for metastatic breast cancer.
    Li L; Li J; Yang K; Tian J; Sun T; Jia W; Zhang P; Yi K
    Future Oncol; 2010 Feb; 6(2):201-7. PubMed ID: 20146579
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combination of capecitabine and mitomycin C as first-line treatment in patients with metastatic breast cancer.
    Vrdoljak E; Boban M; Omrcen T; Hrepic D; Fridl-Vidas V; Boskovic L
    Neoplasma; 2011; 58(2):172-8. PubMed ID: 21275468
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mitomycin C in combination with vinorelbine in anthracycline- and/or taxane-pretreated patients with metastatic breast cancer.
    Schippert C; Warm M; Blohmer JU; du Bois A; Lück HJ
    Onkologie; 2012; 35(9):500-4. PubMed ID: 23007147
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of capecitabine (Xeloda) in breast cancer.
    Kaklamani VG; Gradishar WJ
    Expert Rev Anticancer Ther; 2003 Apr; 3(2):137-44. PubMed ID: 12722873
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gemcitabine and capecitabine in combination for advanced anthracycline and taxane pre-treated breast cancer patients: A phase II study.
    Malmström A; Hansen J; Malmberg L; Carlsson L; Svensson JH; Ahlgren J; Ahlin C; Jansson T; Westberg R
    Acta Oncol; 2010; 49(1):35-41. PubMed ID: 19839920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.